ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Jersey » Geriatric Psychiatry

Top Geriatric Psychiatry Prescribers in New Jersey

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
FRANCIS MURPHY M.D.

Geriatric Psychiatry

3,183

$299K

165
44 are 65+

8%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 28%

$94
Average prescription price

Avg: $104

DAVID MCCOMB D.O.

Geriatric Psychiatry

2,266

$156K

193
189 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 28%

$69
Average prescription price

Avg: $104

MATTHEW BARNAS MD

Geriatric Psychiatry

2,265

$209K

242
228 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 28%

$92
Average prescription price

Avg: $104

CAROL COOPER M.D.

Geriatric Psychiatry

1,996

$295K

154
133 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 28%

$148
Average prescription price

Avg: $104

PRITESH SHAH M.D.

Geriatric Psychiatry

1,827

$245K

171
126 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 28%

$134
Average prescription price

Avg: $104

LINA SHIHABUDDIN MD

Geriatric Psychiatry

1,660

$135K

208
132 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 28%

$81
Average prescription price

Avg: $104

SURINDERJEET SANDHU MD

Geriatric Psychiatry

1,301

$209K

105
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 28%

$160
Average prescription price

Avg: $104

STUART KUSHNER M.D.

Geriatric Psychiatry

1,298

$194K

78
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 28%

$149
Average prescription price

Avg: $104

STEPHEN SCHEINTHAL D.O.

Geriatric Psychiatry

1,071

$81.8K

91
71 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 28%

$76
Average prescription price

Avg: $104

MARTIN FORSBERG M.D.

Geriatric Psychiatry

998

$113K

142
130 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 28%

$113
Average prescription price

Avg: $104

SHAILAJA SHAH MD

Geriatric Psychiatry

854

$125K

51
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 28%

$147
Average prescription price

Avg: $104

STEVEN SAMUELS MD

Geriatric Psychiatry

800

$67.9K

79
58 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 28%

$85
Average prescription price

Avg: $104

AJANTA VINEKAR MD

Geriatric Psychiatry

794

$55K

68
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 28%

$69
Average prescription price

Avg: $104

KENNETH MASTER M.D.

Geriatric Psychiatry

691

$35.4K

84
82 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 28%

$51
Average prescription price

Avg: $104

JUAN RIESTRA M.D.

Geriatric Psychiatry

642

$45K

82
65 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 28%

$70
Average prescription price

Avg: $104

ZEBA NIZAM MD

Geriatric Psychiatry

599

$68.6K

66
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 28%

$114
Average prescription price

Avg: $104

ROBERT GREENBERG M.D.

Geriatric Psychiatry

496

$41.9K

82
75 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 28%

$84
Average prescription price

Avg: $104

LINA SHIHABUDDIN MD LLC

Geriatric Psychiatry

375

$35K

45
28 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 28%

$93
Average prescription price

Avg: $104

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank